Health A Spanish study indicates that four out of ten patients with monkeypox suffer severe forms
Interview "Control measures present difficulties: it is impossible to completely trace each chain of transmission"
Monkeypox The latest news from the infectious outbreak
Despite the fact that cases worldwide have suffered a 6% decline in the last week, according to WHO accounting,
monkeypox infections continue to skyrocket in some specific points
, such as the United States and Spain.
Most of the cases reported in the last four weeks come from Europe (55.9%) and the American continent (42.6%).
The 10 most affected countries worldwide are the United States (10,392),
, Germany (2,982), United Kingdom (2,914), France (2,423), Brazil (2,131), the Netherlands (959), Canada (957 ), Portugal (710) and Italy (599).
these countries account for 88.9% of reported cases worldwide
The shortage of vaccines against the infection has led the
US Food and Drug Administration (FDA)
give the go-ahead to a
new dosage of the vials
That is, up to five people can benefit from each of them.
Europe intends to follow in its footsteps, but not without first verifying that effectiveness is not lost.
European Medicines Agency (EMA)
in a consultation carried out by this means has confirmed that it is studying this option.
Currently, the agency
is analyzing the available data on the Imvanex monkeypox vaccine
from the Danish Bavarian Nordic in order to make a recommendation on the intradermal use of the vaccine during the current public health emergency and thus modify the current one on July 22.
It should be remembered that
the current administration is carried out only subcutaneously (under the skin)
The change he is studying, and which the US has already adopted, is intradermal use (as an injection into the skin), which would require smaller doses and help more people to receive the vaccine.
The change means that the amounts injected decrease from 0.5 ml to 0.1 ml. "Once
the EMA Emergency Working Group has completed the review of the available data, it will issue a recommendation
accordingly," they state from the agency.
Spanish Agency for Medicines and Health Products (Aemps)
has sent a
request to speed up the procedures
and be able to increase the number of people per vial.
The Spanish agency is supported by a study that supports the use of the intradermal vaccine of a lower amount of the vaccine would cause an immune cell response similar to the full dose administered subcutaneously.
Taking this step would mean that, in Spain, Madrid and Catalonia, the regions with the most cases and that have given the most vaccines to date, they would make better use of current resources:
of the 5,300 doses available, more than two thousand
(1,504 in Madrid of a total of 1,835, 1,045 in Catalonia until August 3 of a total of 1,600).
Yesterday the second consignment of 7,110 more doses was received.
The new amounts will serve to alleviate the situation while the EMA pronounces.
Vaccine vials at a vaccination center in Marseille.CHRISTOPHE SIMONAFP
from Europe, our country was assigned a batch of 12,420 doses
that belong to the centralized purchase through the Health Emergency Preparedness and Response Authority (Hera, for its acronym in English) for all its member states,
a total of 109,090 doses of subcutaneous administration
In addition, the European Commission, as Health reported in a statement, which will be distributed throughout the last quarter of 2022.
In the case of the Madrid community, just yesterday it made this request to the Ministry of Health in order to meet the demand for immunization of the population at risk that it carries out in the vaccination centers.
The Department headed by Carolina Darias, awaiting the changes communicated by the EMA, on whom the changes in the use of medicines depend, includes in the Protocol for the use of the vaccine that: "Given the limited availability of vaccines, the The Public Health Commission has established the recommendation to administer a dose, in either of the two strategies used (pre or post exposure).As a public health strategy,
there is scientific evidence
that indicates that
vaccinating a greater number of people with a single dose is more effective than vaccinating half with two doses
Conforms to The Trust Project criteria